Nothing Special   »   [go: up one dir, main page]

DE69627659D1 - Neue thrombin-inhibitoren, deren herstellung und verwendung - Google Patents

Neue thrombin-inhibitoren, deren herstellung und verwendung

Info

Publication number
DE69627659D1
DE69627659D1 DE69627659T DE69627659T DE69627659D1 DE 69627659 D1 DE69627659 D1 DE 69627659D1 DE 69627659 T DE69627659 T DE 69627659T DE 69627659 T DE69627659 T DE 69627659T DE 69627659 D1 DE69627659 D1 DE 69627659D1
Authority
DE
Germany
Prior art keywords
production
thrombin inhibitors
new thrombin
new
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69627659T
Other languages
English (en)
Other versions
DE69627659T2 (de
Inventor
David Gustafsson
Jan-Erik Nystroem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502487A external-priority patent/SE9502487D0/xx
Priority claimed from SE9502504A external-priority patent/SE9502504D0/xx
Priority claimed from SE9502505A external-priority patent/SE9502505D0/xx
Priority claimed from SE9503923A external-priority patent/SE9503923D0/xx
Priority claimed from SE9504349A external-priority patent/SE9504349D0/xx
Priority claimed from GBGB9526411.5A external-priority patent/GB9526411D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69627659D1 publication Critical patent/DE69627659D1/de
Application granted granted Critical
Publication of DE69627659T2 publication Critical patent/DE69627659T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69627659T 1995-07-06 1996-07-02 Neue thrombin-inhibitoren, deren herstellung und verwendung Expired - Fee Related DE69627659T2 (de)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
SE9502487 1995-07-06
SE9502487A SE9502487D0 (sv) 1995-07-06 1995-07-06 New amino acid derivatives
SE9502504 1995-07-07
SE9502505 1995-07-07
SE9502504A SE9502504D0 (sv) 1995-07-07 1995-07-07 New amino acid derivatives
SE9502505A SE9502505D0 (sv) 1995-07-07 1995-07-07 New amino acid derivatives
SE9503923A SE9503923D0 (sv) 1995-11-07 1995-11-07 New amino acid derivatives
SE9503923 1995-11-07
SE9504349 1995-12-05
SE9504349A SE9504349D0 (sv) 1995-12-05 1995-12-05 New amino acid derivatives
GB9526411 1995-12-22
GBGB9526411.5A GB9526411D0 (en) 1995-12-22 1995-12-22 Compounds
PCT/SE1996/000878 WO1997002284A1 (en) 1995-07-06 1996-07-02 New thrombin inhibitors, their preparation and use

Publications (2)

Publication Number Publication Date
DE69627659D1 true DE69627659D1 (de) 2003-05-28
DE69627659T2 DE69627659T2 (de) 2004-03-04

Family

ID=27547251

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627659T Expired - Fee Related DE69627659T2 (de) 1995-07-06 1996-07-02 Neue thrombin-inhibitoren, deren herstellung und verwendung

Country Status (31)

Country Link
US (4) US6051568A (de)
EP (1) EP0836615B1 (de)
JP (1) JP4107682B2 (de)
KR (1) KR100435008B1 (de)
CN (1) CN1147504C (de)
AR (1) AR003440A1 (de)
AT (1) ATE238342T1 (de)
AU (1) AU709710B2 (de)
BR (1) BR9609447A (de)
CA (1) CA2226256C (de)
CZ (1) CZ298487B6 (de)
DE (1) DE69627659T2 (de)
DK (1) DK0836615T3 (de)
EE (1) EE04500B1 (de)
ES (1) ES2197240T3 (de)
HK (1) HK1008995A1 (de)
HU (1) HUP9802315A3 (de)
IL (1) IL122813A0 (de)
IS (1) IS2081B (de)
MX (1) MX9800146A (de)
MY (1) MY116539A (de)
NO (1) NO324092B1 (de)
NZ (2) NZ509474A (de)
PL (1) PL185606B1 (de)
PT (1) PT836615E (de)
RU (1) RU2176645C2 (de)
SA (1) SA96170106A (de)
SI (1) SI0836615T1 (de)
SK (1) SK284695B6 (de)
TR (1) TR199800009T1 (de)
WO (1) WO1997002284A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
SE9602263D0 (sv) 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives
US6200967B1 (en) 1996-06-25 2001-03-13 Eli Lilly And Company Anticoagulant agents
CA2258915A1 (en) * 1996-06-25 1997-12-31 Michael Robert Wiley Anticoagulant agents
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) * 1997-12-05 1997-12-05 Astra Ab New compounds
JP2003529528A (ja) 1998-04-24 2003-10-07 ３−ディメンショナル ファーマシューティカルズ， インコーポレイテッド プロテアーゼインヒビターとしてのアミノ酸アミジノヒドラゾン、アルコキシグアニジン、およびアミノグアニジン
SE9802938D0 (sv) 1998-09-01 1998-09-01 Astra Ab Improved stability for injection solutions
AU1185400A (en) * 1998-11-20 2000-06-13 Banyu Pharmaceutical Co., Ltd. 1-acylazetidine derivatives
SE9804313D0 (sv) 1998-12-14 1998-12-14 Astra Ab New compounds
EP1150996B1 (de) * 1999-01-13 2007-11-21 AstraZeneca AB Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
SE0001803D0 (sv) * 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
NZ523598A (en) * 2000-08-16 2004-10-29 Astrazeneca Ab New amidino derivatives and their use as thrombin inhibitors
US6433186B1 (en) * 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
SE0102921D0 (sv) * 2001-08-30 2001-08-30 Astrazeneca Ab Pharmaceutically useful compounds
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6528503B2 (en) * 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
CA2436176A1 (en) * 2001-02-09 2002-08-22 Merck & Co., Inc. Thrombin inhibitors
SE0101762D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab New use
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
UA78195C2 (uk) * 2001-08-30 2007-03-15 Astrazeneca Ab Похідні мигдалевої кислоти та їх застосування як інгібіторів тромбіну, фармацевтична композиція на їх основі
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201658D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Immediate release pharmaceutical formulation
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
US7524354B2 (en) * 2005-07-07 2009-04-28 Research Foundation Of State University Of New York Controlled synthesis of highly monodispersed gold nanoparticles
TW200827336A (en) 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
IL77748A (en) * 1985-02-04 1991-11-21 Merrell Dow Pharma Amino acid and peptide derivatives as peptidase inhibitors
US5187157A (en) * 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (de) * 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV Protease-Hemmer
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
TW201303B (de) * 1990-07-05 1993-03-01 Hoffmann La Roche
CA2075154A1 (en) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
ZA928581B (en) * 1991-11-12 1994-05-06 Lilly Co Eli Antithrombotic agents
SE9103612D0 (sv) * 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
CA2131367A1 (en) * 1992-03-04 1993-09-16 Sandor Bajusz New anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for the preparation thereof
TW223629B (de) 1992-03-06 1994-05-11 Hoffmann La Roche
US5519193A (en) 1992-10-27 1996-05-21 International Business Machines Corporation Method and apparatus for stressing, burning in and reducing leakage current of electronic devices using microwave radiation
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
US5780631A (en) * 1993-06-03 1998-07-14 Astra Aktiebolag Starting materials in the synthesis of thrombin and kininogenase inhibitors
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
EP0648780A1 (de) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterozyklische Thrombinhemmer
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
AU1025795A (en) * 1994-01-27 1995-08-03 Mitsubishi Chemical Corporation Prolineamide derivatives
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
ZA951617B (en) * 1994-03-04 1997-02-27 Lilly Co Eli Antithrombotic agents.
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5510369A (en) * 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
EP0794777A1 (de) * 1994-11-24 1997-09-17 Janssen Pharmaceutica N.V. Lubeluzolhaltige intravenöse lösungen
MX9706069A (es) * 1995-02-17 1997-10-31 Basf Ag Nuevos inhibidores de la trombina.
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5629324A (en) 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
SE9602263D0 (sv) * 1996-06-07 1996-06-07 Astra Ab New amino acid derivatives

Also Published As

Publication number Publication date
MX9800146A (es) 1998-03-31
US6921758B2 (en) 2005-07-26
CA2226256A1 (en) 1997-01-23
KR100435008B1 (ko) 2004-07-16
TR199800009T1 (xx) 1998-05-21
DK0836615T3 (da) 2003-08-11
SK180497A3 (en) 1998-11-04
PL324483A1 (en) 1998-05-25
WO1997002284A1 (en) 1997-01-23
SI0836615T1 (en) 2003-10-31
CZ421297A3 (cs) 1998-06-17
US6337343B1 (en) 2002-01-08
HUP9802315A3 (en) 1999-03-01
JP4107682B2 (ja) 2008-06-25
NO980015D0 (no) 1998-01-02
SA96170106A (ar) 2005-12-03
US20040087647A1 (en) 2004-05-06
JPH11508591A (ja) 1999-07-27
CZ298487B6 (cs) 2007-10-17
NZ509474A (en) 2005-08-26
IS4639A (is) 1997-12-22
NZ311854A (en) 2000-06-23
US20020042396A1 (en) 2002-04-11
IS2081B (is) 2006-02-15
PT836615E (pt) 2003-09-30
EE04500B1 (et) 2005-06-15
AU709710B2 (en) 1999-09-02
AU6325396A (en) 1997-02-05
EE9700354A (et) 1998-06-15
HUP9802315A2 (hu) 1999-01-28
ATE238342T1 (de) 2003-05-15
RU2176645C2 (ru) 2001-12-10
US6051568A (en) 2000-04-18
MY116539A (en) 2004-02-28
ES2197240T3 (es) 2004-01-01
EP0836615A1 (de) 1998-04-22
NO980015L (no) 1998-02-25
CN1195354A (zh) 1998-10-07
SK284695B6 (sk) 2005-09-08
IL122813A0 (en) 1998-08-16
EP0836615B1 (de) 2003-04-23
CN1147504C (zh) 2004-04-28
BR9609447A (pt) 1999-03-02
US6617320B2 (en) 2003-09-09
DE69627659T2 (de) 2004-03-04
PL185606B1 (pl) 2003-06-30
KR19990028755A (ko) 1999-04-15
AR003440A1 (es) 1998-08-05
NO324092B1 (no) 2007-08-13
CA2226256C (en) 2008-12-30
HK1008995A1 (en) 1999-05-21

Similar Documents

Publication Publication Date Title
DE69627659D1 (de) Neue thrombin-inhibitoren, deren herstellung und verwendung
DE69604285D1 (de) Polysiloxan-polyol makromere, deren herstellung und verwendung
DE69711011D1 (de) Zementzusatz, dessen Herstellungsverfahren und dessen Verwendung
KR970703291A (ko) 다공성 탄소재, 그 제조방법 및 그 용도
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
DE59711847D1 (de) Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung
ATE430734T1 (de) Isochinoline und deren herstellung
DE69620270D1 (de) Backfett und dessen Verwendung
DE69513307D1 (de) Zusammensetzung und verwendung
ATE302604T1 (de) Thienylazolylalkoxyethanamine, deren herstellung und deren verwendung als medikamente
DE59709806D1 (de) Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper
DE69827144D1 (de) Neue blockpolymere und deren herstellung
DE69632678D1 (de) Harzzusammensetzung und deren verwendung
DE69623844D1 (de) Beschichtungszusammensetzung und dessen Verwendung
DE59800590D1 (de) Polymere organosiliciumverbindungen, deren herstellung und verwendung
DE59710272D1 (de) Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
DE69607757D1 (de) Poröse materialbahn
DE59409541D1 (de) Bicyclen-derivate, ihre herstellung und verwendung
DE59711704D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung
DE69630391D1 (de) Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
DE59509446D1 (de) Reaktivfarbstoffe, deren Herstellung und Verwendung
DE69603892D1 (de) Platte zur Herstellung von, aus mehreren Platten bestehenden, Schiebefalttüren
DE69631988D1 (de) Neue alkalische Phosphatase, deren Herstellung und Verwendung
FI960706A0 (fi) Uusi proteiini ja menetelmiä proteiinin valmistamiseksi
DE59606132D1 (de) Neue carbonsäurederivate, ihre herstellung und verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee